Company profile AWH

Aspira Women`s Health Inc
vermillion, inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that hel...p women with serious diseases. the company’s initial in vitro diagnostic test, ova1®, was the first fda-cleared, protein-based in vitro diagnostic multivariate index assay, and represented a new class of software-based liquid biopsy in vitro diagnostics. in march 2016 vermillion received fda clearance for overa™, a second generation ova1 test with significantly improved specificity and ease of use. Show More
Quarter analysis & expected interestLast update: February 08 2024 15:49:51.

After 39 days of this quarter the interest is at 114.0. Based on that we can calculate that during remaining 52 days it will total up to 266.0.
Aspira Women's Health expected interest is significantly higher compared to same quarter last year (+315.6%) but similar to previous quarter.

YearQ1Q2Q3Q4
201970
25
-64.3% QoQ
77
208.0% QoQ
0
-100.0% QoQ
2020 58
-17.1% YoY inf% QoQ
73
192.0% YoY 25.9% QoQ
49
-36.4% YoY -32.9% QoQ
0
-36.4% YoY -100.0% QoQ
2021 113
94.8% YoY inf% QoQ
196
168.5% YoY 73.5% QoQ
63
28.6% YoY -67.9% QoQ
54
inf% YoY -14.3% QoQ
2022 87
-23.0% YoY 61.1% QoQ
27
-86.2% YoY -69.0% QoQ
64
1.6% YoY 137.0% QoQ
102
88.9% YoY 59.4% QoQ
2023 64
-26.4% YoY -37.3% QoQ
47
74.1% YoY -26.6% QoQ
100
56.2% YoY 112.8% QoQ
196
92.2% YoY 96.0% QoQ
2024 114
78.1% YoY -41.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Aspira Women's Health search interestLast update: February 08 2024 15:49:50.
Correlation coefficient between keyword and revenue is -0.07
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 15:49:52.

The average 5 years interest of Aspira Women's Health was 6.05 per week.
The last year interest of Aspira Women's Health compared to the last 5 years has changed by 59.17%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 117.87%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 15:49:57.

After 39 days of this quarter the interest is at 106.0. Based on that we can calculate that during remaining 52 days it will total up to 247.0.
Ova1 blood test expected interest is significantly higher compared to previous quarter (+2370.0%) and same quarter last year (+850.0%).

YearQ1Q2Q3Q4
201912
17
41.7% QoQ
0
-100.0% QoQ
15
inf% QoQ
2020 28
133.3% YoY 86.7% QoQ
33
94.1% YoY 17.9% QoQ
4
inf% YoY -87.9% QoQ
25
66.7% YoY 525.0% QoQ
2021 29
3.6% YoY 16.0% QoQ
32
-3.0% YoY 10.3% QoQ
14
250.0% YoY -56.2% QoQ
30
20.0% YoY 114.3% QoQ
2022 55
89.7% YoY 83.3% QoQ
21
-34.4% YoY -61.8% QoQ
22
57.1% YoY 4.8% QoQ
28
-6.7% YoY 27.3% QoQ
2023 26
-52.7% YoY -7.1% QoQ
8
-61.9% YoY -69.2% QoQ
20
-9.1% YoY 150.0% QoQ
10
-64.3% YoY -50.0% QoQ
2024 106
307.7% YoY 960.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Ova1 blood test search interestLast update: February 08 2024 15:49:56.
Correlation coefficient between keyword and revenue is -0.64
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 15:49:58.

The average 5 years interest of Ova1 blood test was 2.05 per week.
The last year interest of Ova1 blood test compared to the last 5 years has changed by 51.22%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 203.92%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Overa biomarker to provide analysis

Correlation between past revenue and Overa biomarker search interest

There is not enough data for Overa biomarker to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Overa biomarker to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 15:50:03.

After 39 days of this quarter the interest is at 100.0. Based on that we can calculate that during remaining 52 days it will total up to 233.0.
Ovarian cancer risk test expected interest is significantly higher compared to previous quarter (+331.5%) and same quarter last year (+441.9%).

YearQ1Q2Q3Q4
201910
40
300.0% QoQ
16
-60.0% QoQ
4
-75.0% QoQ
2020 24
140.0% YoY 500.0% QoQ
28
-30.0% YoY 16.7% QoQ
31
93.8% YoY 10.7% QoQ
25
525.0% YoY -19.4% QoQ
2021 29
20.8% YoY 16.0% QoQ
39
39.3% YoY 34.5% QoQ
50
61.3% YoY 28.2% QoQ
35
40.0% YoY -30.0% QoQ
2022 73
151.7% YoY 108.6% QoQ
28
-28.2% YoY -61.6% QoQ
22
-56.0% YoY -21.4% QoQ
66
88.6% YoY 200.0% QoQ
2023 43
-41.1% YoY -34.8% QoQ
34
21.4% YoY -20.9% QoQ
39
77.3% YoY 14.7% QoQ
54
-18.2% YoY 38.5% QoQ
2024 100
132.6% YoY 85.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Ovarian cancer risk test search interestLast update: February 08 2024 15:50:03.
Correlation coefficient between keyword and revenue is 0.11
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 15:50:04.

The average 5 years interest of Ovarian cancer risk test was 3.03 per week.
The last year interest of Ovarian cancer risk test compared to the last 5 years has changed by 60.07%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 223.33%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 15:50:10.

After 39 days of this quarter the interest is at 89.0. Based on that we can calculate that during remaining 52 days it will total up to 208.0.
Endometriosis blood test expected interest is significantly lower compared to previous quarter (-65.6%) and same quarter last year (-46.1%).

YearQ1Q2Q3Q4
2019178
246
38.2% QoQ
274
11.4% QoQ
311
13.5% QoQ
2020 177
-0.6% YoY -43.1% QoQ
165
-32.9% YoY -6.8% QoQ
277
1.1% YoY 67.9% QoQ
281
-9.6% YoY 1.4% QoQ
2021 252
42.4% YoY -10.3% QoQ
244
47.9% YoY -3.2% QoQ
269
-2.9% YoY 10.2% QoQ
406
44.5% YoY 50.9% QoQ
2022 279
10.7% YoY -31.3% QoQ
402
64.8% YoY 44.1% QoQ
389
44.6% YoY -3.2% QoQ
331
-18.5% YoY -14.9% QoQ
2023 386
38.4% YoY 16.6% QoQ
581
44.5% YoY 50.5% QoQ
496
27.5% YoY -14.6% QoQ
605
82.8% YoY 22.0% QoQ
2024 89
-76.9% YoY -85.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Endometriosis blood test search interestLast update: February 08 2024 15:50:08.
Correlation coefficient between keyword and revenue is 0.77
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 15:50:11.

The average 5 years interest of Endometriosis blood test was 25.43 per week.
The last year interest of Endometriosis blood test compared to the last 5 years has changed by 48.68%.
The interest for Endometriosis blood test is trending.
The last year interest is quite higher compared to 5 years ago. It has increased by 79.02%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Aspira Women's Health jobs to provide analysis

Correlation between past revenue and Aspira Women's Health jobs search interest

There is not enough data for Aspira Women's Health jobs to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Aspira Women's Health jobs to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Aspira Women's Health reviews to provide analysis

Correlation between past revenue and Aspira Women's Health reviews search interest

There is not enough data for Aspira Women's Health reviews to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Aspira Women's Health reviews to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Aspira Women's Health Texas to provide analysis

Correlation between past revenue and Aspira Women's Health Texas search interest

There is not enough data for Aspira Women's Health Texas to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Aspira Women's Health Texas to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Aspira Women's Health -stock -company to provide analysis

Correlation between past revenue and Aspira Women's Health -stock -company search interest

There is not enough data for Aspira Women's Health -stock -company to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Aspira Women's Health -stock -company to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for AWH
Earnings date: 2024-03-20 After close
Company name: Aspira Women`s Health Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2025-10-29T11:00:00Z

AccessWire
Aspira Women's Health Wins Laboratory Service Contract with University of Texas Medical Branch at Galveston

2025-10-15T16:15:44-04:00

SEC
8-K Form - Current report, item 8.01 - Aspira Women's Health Inc. (0000926617) (Filer)

2025-09-30T17:08:46-04:00

SEC
S-1 Form - General form for registration of securities under the Securities Act of 1933 - Aspira Women's Health Inc. (0000926617) (Filer)

2025-09-25T16:01:42-04:00

SEC
8-K Form - Current report, items 1.01, 3.02, and 9.01 - Aspira Women's Health Inc. (0000926617) (Filer)

2025-09-19T17:26:10-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Aspira Women's Health Inc. (0000926617) (Issuer)

2025-09-19T17:26:04-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Aspira Women's Health Inc. (0000926617) (Issuer)

2025-09-19T17:13:15-04:00

SEC
SCHEDULE 13D/A Form - [Amend] General Statement of Acquisition of Beneficial Ownership - Aspira Women's Health Inc. (0000926617) (Subject)

2025-09-19T16:05:24-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Aspira Women's Health Inc. (0000926617) (Issuer)

2025-09-18T17:15:50-04:00

SEC
D Form - Notice of Exempt Offering of Securities, item 06b - Aspira Women's Health Inc. (0000926617) (Filer)

2025-09-18T09:00:51-04:00

SEC
8-K Form - Current report, items 1.01, 3.02, 8.01, and 9.01 - Aspira Women's Health Inc. (0000926617) (Filer)

2025-09-04T16:05:28-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Aspira Women's Health Inc. (0000926617) (Issuer)

2025-09-04T16:04:19-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - Aspira Women's Health Inc. (0000926617) (Issuer)

2025-09-04T11:00:00Z

AccessWire
Aspira Women's Health Appoints New Chief Financial Officer

2025-09-03T17:22:30-04:00

SEC
8-K Form - Current report, items 5.02 and 9.01 - Aspira Women's Health Inc. (0000926617) (Filer)

2025-07-15T20:01:00Z

AccessWire
Aspira Women's Health Announces Appointment of Jane Pine Wood to the Board of Directors